TNFSF10 and cancer: In contrast, another study found that MSC-FL-TRAIL may cause higher cytotoxicity against cancer cells than MSC-sTRAIL, as well as resistance of cancer cells towards recombinant TRAIL, implying that MSC-FL-TRAIL is superior to MSC-sTRAIL for cancer therapy (108).